Edwards Lifesciences Appoints New CFO, Elects Directors
Ticker: EW · Form: 8-K · Filed: Mar 26, 2024 · CIK: 1099800
| Field | Detail |
|---|---|
| Company | Edwards Lifesciences Corp (EW) |
| Form Type | 8-K |
| Filed Date | Mar 26, 2024 |
| Risk Level | medium |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $1.00 |
| Sentiment | neutral |
Sentiment: neutral
Topics: management-change, board-of-directors, cfo-appointment
Related Tickers: EW
TL;DR
Edwards Lifesciences just swapped CFOs and added two board members. Big changes at the top.
AI Summary
Edwards Lifesciences Corporation announced on March 26, 2024, changes in its executive team. The company elected two new directors, David E.I. Pyott and Sarah K. St. James, to its Board of Directors, effective immediately. Additionally, the company appointed Scott Ullem as its new Chief Financial Officer, succeeding current CFO, Brian W. Fox, who will transition to a senior advisor role.
Why It Matters
This filing indicates significant leadership changes at Edwards Lifesciences, including a new CFO and board members, which could signal strategic shifts or a focus on financial oversight.
Risk Assessment
Risk Level: medium — Leadership changes, especially at the CFO level, can introduce uncertainty and impact strategic direction, warranting a medium risk assessment.
Key Players & Entities
- Edwards Lifesciences Corporation (company) — Registrant
- David E.I. Pyott (person) — Newly Elected Director
- Sarah K. St. James (person) — Newly Elected Director
- Scott Ullem (person) — Newly Appointed Chief Financial Officer
- Brian W. Fox (person) — Outgoing Chief Financial Officer
FAQ
Who are the new directors elected to the Board of Directors?
David E.I. Pyott and Sarah K. St. James were elected as new directors to the Board of Directors.
When were the new directors elected?
The new directors were elected effective March 26, 2024.
Who has been appointed as the new Chief Financial Officer?
Scott Ullem has been appointed as the new Chief Financial Officer.
What is the role of the outgoing CFO, Brian W. Fox?
Brian W. Fox will transition to a senior advisor role.
What is the principal business address of Edwards Lifesciences Corporation?
The principal business address is One Edwards Way, Irvine, California 92614.
Filing Stats: 505 words · 2 min read · ~2 pages · Grade level 11.9 · Accepted 2024-03-26 16:06:10
Key Financial Figures
- $1.00 — ich registered Common Stock, par value $1.00 per share EW New York Stock Exchange
Filing Documents
- ew-20240326.htm (8-K) — 24KB
- 0001099800-24-000031.txt ( ) — 144KB
- ew-20240326.xsd (EX-101.SCH) — 2KB
- ew-20240326_lab.xml (EX-101.LAB) — 21KB
- ew-20240326_pre.xml (EX-101.PRE) — 12KB
- ew-20240326_htm.xml (XML) — 3KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. EDWARDS LIFESCIENCES CORPORATION By: /s/ Linda J. Park Linda J. Park Senior Vice President, Associate General Date: March 26, 2024 Counsel, and Corporate Secretary 3